Atlas Trials

Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants

Clinical trial NCT04223635 · COMPLETED

Trial details

NCT number
NCT04223635
Sponsor
Daiichi Sankyo
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Moderate Hepatic Impairment
Start date
2020-01-07
Primary completion
2020-10-02
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.